The Pathogenesis of Tuberculosis-The Koch Phenomenon Reinstated.
Open accessThe DOI matches its Crossref record; 136 of the 140 references it cites were found in a registry or an index.
Abstract
Research on the pathogenesis of tuberculosis (TB) has been hamstrung for half a century by the paradigm that granulomas are the hallmark of active disease. Human TB, in fact, produces two types of granulomas, neither of which is involved in the development of adult type or post-primary TB. This disease begins as the early lesion; a prolonged subclinical stockpiling of secreted mycobacterial antigens in foamy alveolar macrophages and nearby highly sensitized T cells in preparation for a massive necrotizing hypersensitivity reaction, the Koch Phenomenon, that produces caseous pneumonia that is either coughed out to form cavities or retained to become the focus of post-primary granulomas and fibrocaseous disease. Post-primary TB progresses if the antigens are continuously released and regresses when they are depleted. This revised paradigm is supported by nearly 200 years of research and suggests new approaches and animal models to investigate long standing mysteries of human TB and vaccines that inhibit the early lesion to finally end its transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Tree-in-bud sign on CT scans was recently rediscovered as the characteristic early lesion of PPTB. It was described by Carswell in 1837 and by X-rays in the 1920s [42,46,50]. Today, it is recognized as characteristic of advancing post-primary TB.](https://figures.cochat.ai/paper-figures/f6254c25ca974ee7a49b4b817b460dc5/the-pathogenesis-of-tuberculosis-the-koch-phenomenon-reinstated-figure-3.jpg)


![Figure 6 Granulomas of primary TB have homogeneous caseum with peripheral lipids. Granulomas of PPTB consist of ghosts of alveoli (light-colored cracks are alveolar walls) surrounded by granuloma. They are found naturally only in human lungs and form to encase to unexpelled caseous pneumonia [18]. (H&E stain 4×).](https://figures.cochat.ai/paper-figures/114f4ee3f86c4a069df3c8e9390c7f1a/the-pathogenesis-of-tuberculosis-the-koch-phenomenon-reinstated-figure-6.jpg)
![Figure 7 Caseating granulomas in humans and mice. Contrary to widespread belief, mice are able to develop several types of caseating granulomas each of which resembles a type of human lesion. This requires that one duplicate the conditions that occur in humans when the lesions develop rather than the route and dose of infection [135] (H&E stain Left and center) (Connective tissue stain, Right, showing a fibrous capsule).](https://figures.cochat.ai/paper-figures/68a67743d1e64242a22ded4d1e52ca38/the-pathogenesis-of-tuberculosis-the-koch-phenomenon-reinstated-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has been suggested that mycobacterial antigens tend to accumulate at the site of disease and this accumulation rather than the bacillary load is the central phenomenon in TB pathogenesis and tissue destruction [26, 27].”
From Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates (2022) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Foamy macrophages and the progression of the human tuberculosis granuloma
Russell, D. G., Cardona, P.-J., Kim, M.-J., Allain, S., & Altare, F. (2009) · Nature Immunology · doi:10.1038/ni.1781 · Cited by 827
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
Comas, I., Chakravartti, J., Small, P. M., Galagan, J., Niemann, S., Kremer, K., Ernst, J. D., & Gagneux, S. (2010) · Nature Genetics · doi:10.1038/ng.590 · Cited by 707
THE PATHOGENESIS OF TUBERCULOSIS
(1952) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1952.tb94689.x · Cited by 692
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Ancient Origin and Gene Mosaicism of the Progenitor of Mycobacterium tuberculosis
Gutierrez, M. C., Brisse, S., Brosch, R., Fabre, M., Omaïs, B., Marmiesse, M., Supply, P., & Vincent, V. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010005 · Cited by 646 · cited 2×
“It is a very successful human parasite that has coevolved with humans for many thousands, if not millions, of years [17].”
BackgroundA new biology for a new century
Woese, C. R. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.173-186.2004 · Cited by 641
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
Research works printed but not linked: 17
- Kayne G.G. Pagel W. O’Shaughenessy L. Pulmonary Tuberculosis, Pathology, Diagnosis, Management and Prevention Oxford University Press London, UK 1948
- Opie E. Phhistogenesis and Latent Tuberculosus Infection Am. Rev. Tuberc. 1922 6 525 546
- Anonymous 2019 Update WHO Guidelines on Tuberculosis Infection Prevention and Control World Health Organization Geneva, Switzerland 2019 30933444
- Youmans G.P. Chapter 13. Relationship between delayed hypersensitivity and immunity in tuberculosis Tuberculosis Youmans G.P. W.B. Saunders Co. Philadelphia, PA, USA 1979 302 326
- Levine E.R. Chapter 7, Classification of reinfection pulmonary tuberculosis The Fundamentals of Pulmonary Tuberculosis and its Complications for Students, Teachers and Practicing Physicians. Sponsored by The American College of Physicians Hayes E. Charles C. Thomas Springfield, IL, USA 1949 97 113
- Amberson J.B. The Significance of Roentgenographic Mutations of The Lesions of Chronic Pulmonary Tuberculosis Am. Rev. Tuberc. 1922 6 591 610
- Ophuls W. Statistical survey of tuberculosis on the basis of a series of 3000 post-mortem examinations National Tuberculosis Association Transactions of the Nineteenth Annual Meeting Hamilton Printing Co Albany New York, NY, USA 1923 252 256
- Kerley P. Discussion on the Early Diagniosis of Pulmonary Tuberculosis Proc. R. Soc. Med. 1933 27 164 167
- Gunn F.D. Tuberculosis Pathology 4th ed. Anderson W.A.D. C.V. Mosby Company St. Louis, MO, USA 1961 243 263
- Reuter H. Wood R. Schaaf H.S. Donald P.R. Chapter 34 Overview of extrapulmonary tuberculosis in adults and children Tuberculosis. A Comprehensive Clinical Reference Schaaf H. Zumla A.A. Elsevier Inc. Amsterdam, The Netherlands 2009 377 390
- Osler W. McCrae T. Chapter XXI, tuberculosis The Principles and Practice of Medicine 9th ed. D. Appleton and Company New York, NY, USA London, UK 1921 184 255
- Hektoen L. Reisman D. A Text-Book of Pathology for the Use of Students and Practitoners of Medicine and Surgery W.B. Saunders & Company London, UK Philadelphia, PA, USA 1901
- Broch B.L. Chapter 14, The role of the bronchial tree in the pathogenesis of pulmonary tuberculosis The Fundamentals of Pulmonary Tuberculosis and Its Complications for Students, Teachers and Practicing Physicians Hayes E. Charles C. Thomas Springfield, IL, USA 1949 245 253
- Daley C.L. Gotway M. Chapter 24 Imaging of tuberculosis in adults Tuberculosis. A Comprehensive Clinical Reference Schaaf H. Zumla A.A. Elsevier Inc. Amsterdam, The Netherlands 2009 237 261
- Middlebrook G. General discussion of Bloch’s paper CIBA Foundation Symposium on Experimental Tuberculosis Wolstenholme G. Little Brown & Co. Boston, MA, USA 1995 142
- Walsh J. The Clinical Pathology of Pulmonary Tuberculosis in Adults. An Analysis of 500 Necropsies Personally Reformed or Observed Am. Rev. Tuberc. 1922 6 975 993
- National Research Council A New Biology for the 21st Century The National Academies Press Washington, DC, USA 2009
Cited by
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Immune cell interactions in tuberculosis
Flynn, J. L., & Chan, J. (2022) · Cell · doi:10.1016/j.cell.2022.10.025 · Cited by 176
Tiwari, D., & Martineau, A. R. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101672 · Cited by 125
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis
Weeratunga, P. N., Möller, D. R., & Ho, L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175264 · Cited by 103
Immunopathology in human tuberculosis
Scriba, T. J., Maseeme, M., Young, C., Taylor, L. J., & Leslie, A. J. (2024) · Science Immunology · doi:10.1126/sciimmunol.ado5951 · Cited by 62
Metadata
- Authors
- Hunter, R. L.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Hunter, Robert L.
- ORCID
- Hunter, Robert L.
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2020-10-04
- Volume
- 9
- Issue
- 10
- Pages
- 813
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC7601602
- OpenAlex
- W3089651222
- Cited by
- 67
- References
- 140
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 12
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis pathogenesis, granuloma, post-primary tuberculosis, early lesions, mycobacterial antigens, alveolar macrophages, T cell sensitization, caseous pneumonia, animal models, tuberculosis vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.